‘CDC officials hold meeting to discuss Covid-19 vaccine booster shots’ -CNBC Television
https://www.youtube.com/watch?v=MA7eG_p0EZc
Earnings Magic: Disney Provides Reopening Optimism With “Bullish” Theme Park Results
When it comes to reopening, there aren’t many better barometers than Disney (NYSE: DIS). From theme parks to movie theaters to resorts, the company has a finger in lots of pies.
Moderna’s Shot Seems To Have A Better Shot Against Delta Than Pfizer’s
Besides proudly stating that its Covid-19 shot produced a "robust" antibody response against the highly contagious delta variant last Thursday, Moderna (NASDAQ: MRNA) also posted second-quarter financial results that beat Wall Street's expectations on both earnings and revenue.
Top 20 Trending Stocks On WallStreetBets As Of Friday, Aug. 13, 2021 (Via Swaggy Stocks)
Data from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment
ContextLogic (WISH)
SoFi Technologies (SOFI)
Walt Disney (DIS)
Clover Health Investments (CLOV)
Palantir Technologies (PLTR)
Tesla
Moderna Announces FDA Authorization of Third Dose of COVID-19 Vaccine for Immunocompromised Individuals
Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines today announced that the U.S. Food and Drug Administration (FDA) has approved an update to the emergency use
Moderna’s COVID-19 Vaccine Retains Antibodies Against Variants For 6 Months
Moderna Inc (NASDAQ:MRNA) announced the publication of a new study showing that its COVID-19 vaccine led to durable antibody levels against…
FDA Approves Vaccine Booster Dose Of mRNA COVID-19 Vaccines For Small, Vulnerable Group
The FDA has authorized a third COVID-19 vaccine booster shot to immunocompromised individuals who have already received two mRNA shots, citing their need for extra protection from the infection.
The Daily Biotech Pulse: Moderna’s Vaccine Produces Durable Response Against Variants, FDA Approves Jazz’s Sleep Disorder Drug, Dermata IPO
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 12)
Cramer Shares His Thoughts On Moderna, Nvidia And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said Karyopharm Therapeutics Inc (NASDAQ: KPTI) is nothing special.